TrianglePUBLICATIONS · 16782917
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2006 Jun 20
- First author
- Robert N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Robert N
- type
- Author
- name
- Leyland-Jones B
- type
- Author
- name
- Asmar L
- type
- Author
- name
- Belt R
- type
- Author
- name
- Ilegbodu D
- type
- Author
- name
- Loesch D
- type
- Author
- name
- Raju R
- type
- Author
- name
- Valentine E
- type
- Author
- name
- Sayre R
- type
- Author
- name
- Cobleigh M
- type
- Author
- name
- Albain K
- type
- Author
- name
- McCullough C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Robert N
- type
- Author
- name
- Leyland-Jones B
- type
- Author
- name
- Asmar L
- type
- Author
- name
- Belt R
- type
- Author
- name
- Ilegbodu D
- type
- Author
- name
- Loesch D
- type
- Author
- name
- Raju R
- type
- Author
- name
- Valentine E
- type
- Author
- name
- Sayre R
- type
- Author
- name
- Cobleigh M
- type
- Author
- name
- Albain K
- type
- Author
- name
- McCullough C
- type
- Author
- bibliography ids
- nci-bib-3a529ef71f54a8426bbc315b
- book metadata
- content sha256
- 8e6d12ed09d9c17736000aab2c2acbeb708433163e8319fcc4b9a714e4c227db
- document type
- citation
- dois
- 10.1200/JCO.2005.04.1764
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16782917
- immutable id
- pubmed:16782917@8e6d12ed09d9c17736000aab2c2acbeb708433163e8319fcc4b9a714e4c227db
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 18
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2786-92
- volume
- 24
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16782917
- provenance
- batch id
- 19fb2de9a00882c94e86
- provider
- NCBI PubMed ESummary
- record sha256
- 14bf6d18546c11d418b13075b2272b9998318889e5e28cdf431ee048a7fb83e2
- response sha256
- 4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
- retrieved at
- 2026-09-09T23:46:06.810486+00:00
- publication date
- display
- 2006 Jun 20
- precision
- day
- year
- 2006
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Preserved source evidence · Not medical advice